Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years

Uma Borate, Brianna Norris, Abby Statler, Rongwei Fu, Taylor Bucy, Mikkael A. Sekeres

Blood Advances · 2019 · 15 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

Key Points Patients with t-MDS are underrepresented in clinical trials when taking into account the prevalence of such patients. Eligibility criteria and sponsorship type may contribute to t-MDS patient exclusion.

References

39